Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

Methadone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methadone hydrochloride and what is the scope of patent protection?

Methadone hydrochloride
is the generic ingredient in five branded drugs marketed by Aurolife Pharma Llc, Vistapharm, Sandoz, Roxane, Mallinckrodt, Mylan Institutional, West-ward Pharms Int, The Pharmanetwork, Mallinckrodt Inc, and Corepharma, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for methadone hydrochloride. Nineteen suppliers are listed for this compound.

Summary for Generic Name: methadone hydrochloride

Drug Master File Entries: see list13
Suppliers / Packagers: see list19
Bulk Api Vendors: see list11
Clinical Trials: see list1,075
Patent Applications: see list6,128
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methadone hydrochloride at DailyMed

Pharmacology for Ingredient: methadone hydrochloride

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
methadone hydrochloride
CONCENTRATE;ORAL040180-001Apr 30, 1998AARXNoNo► Subscribe► Subscribe
methadone hydrochloride
TABLET;ORAL088108-001Mar 8, 1983DISCNNoNo► Subscribe► Subscribe
Mylan Institutional
methadone hydrochloride
INJECTABLE;INJECTION021624-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
methadone hydrochloride
TABLET;ORAL040050-002Apr 15, 1993AARXNoNo► Subscribe► Subscribe
Aurolife Pharma Llc
methadone hydrochloride
TABLET;ORAL203502-001Aug 31, 2015AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus